Jennifer E Klomp

6PUBLICATIONS
55CO-AUTHORS
Molecular targetsSignal transduction
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 30, 2025
Defining the MYC-regulated transcriptome and kinome that support KRAS- and ERK-dependent growth of pancreatic cancer.

Priya S Hibshman, Clint A Stalnecker, Jeffrey A Klomp

|Jun 06, 2024
Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers.

Jeffrey A Klomp, Jennifer E Klomp, Clint A Stalnecker

|Jun 06, 2024
Determining the ERK-regulated phosphoproteome driving KRAS-mutant cancer.

Jennifer E Klomp, J Nathaniel Diehl, Jeffrey A Klomp

|Nov 07, 2023
TEAD Inhibition Overcomes YAP1/TAZ-Driven Primary and Acquired Resistance to KRASG12C Inhibitors.

A Cole Edwards, Clint A Stalnecker, Alexis Jean Morales

|Nov 08, 2022
Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer.

Craig M Goodwin, Andrew M Waters, Jennifer E Klomp

|Dec 14, 2016
Mimicking transient activation of protein kinases in living cells.

Jennifer E Klomp, Vincent Huyot, Anne-Marie Ray

Pageof 1